Barclays analyst Benjamin Budish raised the firm’s price target on Marex Group (MRX) to $44 from $43 and keeps an Overweight rating on the shares as part of a Q1 preview for the brokers, asset managers and exchanges. With volatility “in full swing,” mergers and initial public offering pipelines are likely to see further delays, the analyst tells investors in a research note. The firm says that while trading activity was generally robust despite a slowdown in crypto, brokers “now face a more intense headwind from a lower in-period Fed funds and futures curve.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRX:
- Marex Group price target raised to $45 from $36 at Keefe Bruyette
- Marex Group Announces First AGM Post-IPO
- Marex Group Reports Strong Q1 2025 Results Amid Positive Market Conditions
- Marex Group sees Q1 adjusted EPS 88c-93c, consensus 77c
- Marex Group’s 2024 Annual Report Highlights Successful Nasdaq Debut and Strong Financial Growth